Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
James F. Howard$suffix/text()$suffix/text(), John Vissing, Nils E. Gilhus, M. Isabel Leite, Kimiaki Utsugisawa, Petra W. Duda, Ramin Farzaneh-Far, Hiroyuki Murai & Heinz Wiendl. (2021) Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody–Positive Generalized Myasthenia Gravis. Expert Opinion on Investigational Drugs 30:5, pages 483-493.
Read now
Read now
Hayeong Rho & Richard A Wells. (2020) Ravulizumab in the treatment of paroxysmal nocturnal hemoglobinuria. Expert Opinion on Orphan Drugs 8:8, pages 257-264.
Read now
Read now
Olaia F Vila, Yihuai Qu & Gordana Vunjak-Novakovic. (2020) In vitro models of neuromuscular junctions and their potential for novel drug discovery and development. Expert Opinion on Drug Discovery 15:3, pages 307-317.
Read now
Read now
Articles from other publishers (30)
Rebecca Golfinopoulou, Véronique Giudicelli, Taciana Manso & Sofia Kossida. (2023) Delving into Molecular Pathways: Analyzing the Mechanisms of Action of Monoclonal Antibodies Integrated in IMGT/mAb-DB for Myasthenia Gravis. Vaccines 11:12, pages 1756.
Crossref
Crossref
Guo-Qing Tang, Yalan Tang, Ketki Dhamnaskar, Michelle D. Hoarty, Rohit Vyasamneni, Douangsone D. Vadysirisack, Zhong Ma, Nanqun Zhu, Jian-Guo Wang, Charlie Bu, Bestine Cong, Elizabeth Palmer, Petra W. Duda, Camil Sayegh & Alonso Ricardo. (2023) Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation. Frontiers in Immunology 14.
Crossref
Crossref
Tanya R Riley, Janine S Douglas, Christopher Wang & Kiarra M Bowser. (2023) An update of the pharmacological treatment options for generalized myasthenia gravis in adults with anti–acetylcholine receptor antibodies. American Journal of Health-System Pharmacy 80:11, pages 652-662.
Crossref
Crossref
James F HowardJrJr, Saskia Bresch, Angela Genge, Channa Hewamadduma, John Hinton, Yessar Hussain, Raul Juntas-Morales, Henry J Kaminski, Angelina Maniaol, Renato Mantegazza, Masayuki Masuda, Kumaraswamy Sivakumar, Marek Śmiłowski, Kimiaki Utsugisawa, Tuan Vu, Michael D Weiss, Małgorzata Zajda, Babak Boroojerdi, Melissa Brock, Guillemette de la Borderie, Petra W Duda, Romana Lowcock, Mark Vanderkelen, M Isabel Leite, Dylan Sembinelli, Jeanne Teitelbaum, Michael Nicolle, Emilien Bernard, Juliette Svahn, Marco Spinazzi, Tanya Stojkovic, Sophie Demeret, Nicolas Weiss, Loïc Le Guennec, Sihame Messai, Christine Tranchant, Aleksandra Nadaj-Pakleza, Jean-Baptiste Chanson, Muhtadi Suliman, Leila Zaidi, Celine Tard, Peggy Lecointe, Jana Zschüntzsch, Jens Schmidt, Stefanie Glaubitz, Rachel Zeng, Matthias Scholl, Markus Kowarik, Ulf Ziemann, Markus Krumbholz, Pascal Martin, Christoph Ruschil, Jutta Dünschede, Roswitha Kemmner, Natalie Rumpel, Benjamin Berger, Andreas Totzeck, Tim Hagenacker, Benjamin Stolte, Raffaele Iorio, Amelia Evoli, Silvia Falso, Carlo Antozzi, Rita Frangiamore, Fiammetta Vanoli, Elena Rinaldi, Kazushi Deguchi, Naoya Minami, Yuriko Nagane, Yasushi Suzuki, Sayaka Ishida, Shigeaki Suzuki, Jin Nakahara, Astushi Nagaoka, Shunsuke Yoshimura, Shingo Konno, Youko Tsuya, Akiyuki Uzawa, Tomoya Kubota, Masanori Takahashi, Tatsusada Okuno, Hiroyuki Murai, Nils Erik Gilhus, Marion Boldingh, Tone Hakvåg Rønning, Urszula Chyrchel-Paszkiewicz, Klaudiusz Kumor, Tomasz Zielinski, Krzysztof Banaszkiewicz, Michał Błaż, Agata Kłósek, Mariola Świderek-Matysiak, Andrzej Szczudlik, Aneta Paśko, Lech Szczechowski, Marta Banach, Jan Ilkowski, Solange Kapetanovic Garcia, Patricia Ortiz Bagan, Ana Belén Cánovas Segura, Joana Turon Sans, Nuria Vidal Fernandez, Elena Cortes Vicente, Patricia Rodrigo Armenteros, Mohammad Ashraghi, Ana Cavey, Liam Haslam, Anna Emery, Kore Liow, Sharon Yegiaian, Alexandru Barboi, Rosa Maria Vazquez, Joshua Lennon, Robert M Pascuzzi, Cynthia Bodkin, Sandra Guingrich, Adam Comer, Mark Bromberg, Teresa Janecki, Sami Saba, Marco Tellez, Bakri Elsheikh, Miriam Freimer, Sarah Heintzman, Raghav Govindarajan, Jeffrey Guptill, Janice M Massey, Vern Juel, Natalia Gonzalez, Ali A Habib, Tahseen Mozaffar, Manisha Korb, Namita Goyal, Hannah Machemehl, Georgios Manousakis, Jeffrey Allen, Emily Harper, Constantine Farmakidis, Lilli Saavedra, Mazen Dimachkie, Mamatha Pasnoor, Salma Akhter, Said Beydoun, Courtney McIlduff, Joan Nye, Bhaskar Roy, Bailey Munro Sheldon, Richard Nowak, Benjamin Barnes, Michael Rivner, Niraja Suresh, Jessica Shaw, Brittany Harvey, Lucy Lam, Nikki Thomas, Manisha Chopra, Rebecca E Traub, Sarah Jones, Mary Wagoner, Sejla Smajic, Radwa Aly, Jonathan Katz, Henry Chen, Robert G Miller, Liberty Jenkins, Shaida Khan, Bhupendra Khatri, Lisa Sershon, Pantelis Pavlakis, Shara Holzberg, Yuebing Li, Irys B Caristo, Robert Marquardt, Debbie Hastings, Jacob Rube, Robert P Lisak, Aparna Choudhury, Katherine Ruzhansky, Amit Sachdev, Susan Shin, Joan Bratton, Mary Fetter, Naya McKinnon, Jonathan McKinnon, Laura Sissons-Ross, Amos Sahu & B Jane Distad. (2023) Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study. The Lancet Neurology 22:5, pages 395-406.
Crossref
Crossref
Kazuo IwasaYutaka FurukawaHiroaki YoshikawaMasahito YamadaKenjiro Ono. (2023) CD59 Expression in Skeletal Muscles and Its Role in Myasthenia Gravis. Neurology Neuroimmunology & Neuroinflammation 10:1.
Crossref
Crossref
Christopher Nelke, Christina B Schroeter, Frauke Stascheit, Marc Pawlitzki, Liesa Regner-Nelke, Niklas Huntemann, Ercan Arat, Menekse Öztürk, Nico Melzer, Philipp Mergenthaler, Asmae Gassa, Henning Stetefeld, Michael Schroeter, Benjamin Berger, Andreas Totzeck, Tim Hagenacker, Stefanie Schreiber, Stefan Vielhaber, Hans-Peter Hartung, Andreas Meisel, Heinz Wiendl, Sven G Meuth & Tobias Ruck. (2022) Eculizumab versus rituximab in generalised myasthenia gravis. Journal of Neurology, Neurosurgery & Psychiatry 93:5, pages 548-554.
Crossref
Crossref
Jaap J. Plomp, Maartje G.M. Huijbers, Jan J.G.M. Verschuuren & Anna Borodovsky. (2022) A bioassay for neuromuscular junction-restricted complement activation by myasthenia gravis acetylcholine receptor antibodies. Journal of Neuroscience Methods 373, pages 109551.
Crossref
Crossref
Saranya B Gomathy, Ayush Agarwal & Venugopalan Y Vishnu. (2022) Molecular Therapy in Myasthenia Gravis. Neurology 18:1, pages 49.
Crossref
Crossref
Mariela L. Paz & Francisco J. Barrantes. (2021) Cholesterol in myasthenia gravis. Archives of Biochemistry and Biophysics 701, pages 108788.
Crossref
Crossref
Y. Ozawa, A. Uzawa, M. Yasuda, Y. Kojima, F. Oda, K. Himuro, N. Kawaguchi & S. Kuwabara. (2020) Changes in serum complements and their regulators in generalized myasthenia gravis. European Journal of Neurology 28:1, pages 314-322.
Crossref
Crossref
Ikjae Lee & Gil I. Wolfe. 2021. Neurotherapeutics in the Era of Translational Medicine. Neurotherapeutics in the Era of Translational Medicine
243
264
.
Sorabh Datta, Shivangi Singh & Raghav Govindarajan. (2020) Retrospective Analysis of Eculizumab in Patients with Acetylcholine Receptor Antibody-Negative Myasthenia Gravis: A Case Series. Journal of Neuromuscular Diseases 7:3, pages 269-277.
Crossref
Crossref
Mitsugu Yanagidaira, Yoichiro Nishida & Takanori Yokota. (2020) Temporal correlation between serum CH50 level and symptom severity of myasthenia gravis during eculizumab therapy. Clinical Neurology and Neurosurgery 189, pages 105630.
Crossref
Crossref
Florencia Aguirre, Analisa Manin, Victoria C. Fernandez, Mariano E. Justo, Juliana Leoni, Mariela L. Paz & Andres M. Villa. (2020) C3, C5a and anti-acetylcholine receptor antibody as severity biomarkers in myasthenia gravis. Therapeutic Advances in Neurological Disorders 13, pages 175628642093569.
Crossref
Crossref
Mariela L. Paz & Francisco J. Barrantes. (2019) Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets. ACS Chemical Neuroscience 10:5, pages 2186-2194.
Crossref
Crossref
Loulwah Mukharesh & Henry J. Kaminski. (2019) A Neurologist’s Perspective on Understanding Myasthenia Gravis. Thoracic Surgery Clinics 29:2, pages 133-141.
Crossref
Crossref
Saiju Jacob. (2018) Myasthenia Gravis – A Review of Current Therapeutic Options. European Neurological Review 13:2, pages 86.
Crossref
Crossref
James F. HowardJr.Jr.. (2018) Myasthenia gravis: the role of complement at the neuromuscular junction. Annals of the New York Academy of Sciences 1412:1, pages 113-128.
Crossref
Crossref
Hadi Abou-El-Hassan & Hassan Zaraket. (2016) Viral-derived complement inhibitors: current status and potential role in immunomodulation. Experimental Biology and Medicine 242:4, pages 397-410.
Crossref
Crossref
Edimara S. Reis, Dimitrios C. Mastellos, Despina Yancopoulou, Antonio M. Risitano, Daniel Ricklin & John D. Lambris. (2015) Applying complement therapeutics to rare diseases. Clinical Immunology 161:2, pages 225-240.
Crossref
Crossref
Shannon J. Beasley & Judith M. Greer. (2015) Autoantibodies and their potential roles in diseases of the nervous system. Clinical and Experimental Neuroimmunology 6:4, pages 370-386.
Crossref
Crossref
Linda L. Kusner & Henry J. Kaminski. 2015. Neurobiology of Brain Disorders. Neurobiology of Brain Disorders
135
150
.
Sonia Berrih-Aknin. (2014) Myasthenia Gravis: Paradox versus paradigm in autoimmunity. Journal of Autoimmunity 52, pages 1-28.
Crossref
Crossref
Linda L. Kusner, Namita Satija, Georgiana Cheng & Henry J. Kaminski. (2014) Targeting therapy to the neuromuscular junction: Proof of concept. Muscle & Nerve 49:5, pages 749-756.
Crossref
Crossref
Henry J. Kaminski. 2014. Neuromuscular Disorders in Clinical Practice. Neuromuscular Disorders in Clinical Practice
1075
1088
.
Linda L. Kusner, Jose A. Halperin & Henry J. Kaminski. (2012) Cell surface complement regulators moderate experimental myasthenia gravis pathology. Muscle & Nerve 47:1, pages 33-40.
Crossref
Crossref
Henry J. Kaminski, Linda L. Kusner, Gil I. Wolfe, Inmaculada Aban, Greg Minisman, Robin Conwit & Gary Cutter. (2012) Biomarker development for myasthenia gravis. Annals of the New York Academy of Sciences 1275:1, pages 101-106.
Crossref
Crossref
Jindrich Soltys, Jose A. Halperin & Qin Xuebin. (2012) DAF/CD55 and Protectin/CD59 modulate adaptive immunity and disease outcome in experimental autoimmune myasthenia gravis. Journal of Neuroimmunology 244:1-2, pages 63-69.
Crossref
Crossref
Jindrich Soltys, Linda L. Kusner, Andrew Young, Chelliah Richmonds, Denise Hatala, Bendi Gong, Vaithesh Shanmugavel & Henry J. Kaminski. (2009) Novel complement inhibitor limits severity of experimentally myasthenia gravis. Annals of Neurology 65:1, pages 67-75.
Crossref
Crossref
Jindrich Soltys, Bendi Gong, Henry J. Kaminski, Yuefang Zhou & Linda L. Kusner. (2008)
Extraocular Muscle Susceptibility to Myasthenia Gravis
. Annals of the New York Academy of Sciences 1132:1, pages 220-224.
Crossref
Crossref